| Company/Division name | Philips Sleep & Respiratory Care |
| Parent company | Philips Respironics |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2021 |
| Year reshoring implemented or to be implemented: | 2021 |
| Domestically, the work will be done: | In-house |
| Country(ies) from which reshored: | United Kingdom |
| City reshored to: | Pittsburgh |
| State(s) reshored to: | PA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | respiratory drug delivery breathing devices |
| What domestic positive factors made reshoring more attractive? | Customer responsiveness improvement, Higher productivity, Infrastructure, Manufacturing/engineering joint innovation (R&D), Under-utilized capacity |
